Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Reverter

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Fondaparinux sodiumJ C Reverter
Cancer Treatment Reports|May 1, 1986
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustineF Cervantes, J C Reverter, E Montserrat, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stagesE Montserrat, N Viñolas, J C Reverter, et al.
British Journal of Diseases of the Chest|October 1, 1987
Erythema nodosum and pulmonary solitary nodule as the first manifestations of a non-Hodgkin's lymphomaJ C Reverter, A Coca, J Font, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 13, 2000
Interaction between interleukin-6 and the natural anticoagulant system in acute strokeN Vila, J C Reverter, J Yagüe, et al.
European Journal of Haematology|May 1, 1990
Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: analysis of their clinical significanceS Molica, J C Reverter, A Alberti, et al.
Leukemia & Lymphoma|July 28, 2016
Efficacy of ABVD Therapy in Resistant Hodgkin's DiseaseE Montserrat, J M Martí, J C Reverter, et al.
Leukemia & Lymphoma|July 28, 2016
"Smouldering" Chronic Lymphocytic LeukemiaE Montserrat, N Viñolas, J C Reverter, et al.
British Journal of Haematology|August 1, 1989
A new prognostic system for multiple myeloma based on easily available parametersJ Bladé, C Rozman, F Cervantes, et al.
Archives of Dermatology|October 1, 1991
Prognostic clinicopathologic factors in cutaneous T-cell lymphomaR M Martí, T Estrach, J C Reverter, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Fondaparinux sodiumJ C Reverter
Cancer Treatment Reports|May 1, 1986
Treatment of advanced resistant Hodgkin's disease with lomustine, etoposide, and prednimustineF Cervantes, J C Reverter, E Montserrat, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stagesE Montserrat, N Viñolas, J C Reverter, et al.
British Journal of Diseases of the Chest|October 1, 1987
Erythema nodosum and pulmonary solitary nodule as the first manifestations of a non-Hodgkin's lymphomaJ C Reverter, A Coca, J Font, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 13, 2000
Interaction between interleukin-6 and the natural anticoagulant system in acute strokeN Vila, J C Reverter, J Yagüe, et al.
European Journal of Haematology|May 1, 1990
Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: analysis of their clinical significanceS Molica, J C Reverter, A Alberti, et al.
Leukemia & Lymphoma|July 28, 2016
Efficacy of ABVD Therapy in Resistant Hodgkin's DiseaseE Montserrat, J M Martí, J C Reverter, et al.
Leukemia & Lymphoma|July 28, 2016
"Smouldering" Chronic Lymphocytic LeukemiaE Montserrat, N Viñolas, J C Reverter, et al.
British Journal of Haematology|August 1, 1989
A new prognostic system for multiple myeloma based on easily available parametersJ Bladé, C Rozman, F Cervantes, et al.
Archives of Dermatology|October 1, 1991
Prognostic clinicopathologic factors in cutaneous T-cell lymphomaR M Martí, T Estrach, J C Reverter, et al.
Pageof 13